AMBONI, Marianna
 Distribuzione geografica
Continente #
NA - Nord America 4.666
EU - Europa 1.453
AS - Asia 1.062
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
SA - Sud America 1
Totale 7.189
Nazione #
US - Stati Uniti d'America 4.657
CN - Cina 460
IT - Italia 340
UA - Ucraina 332
SG - Singapore 260
DE - Germania 212
IE - Irlanda 190
TR - Turchia 167
SE - Svezia 142
VN - Vietnam 136
RU - Federazione Russa 83
FI - Finlandia 60
GB - Regno Unito 40
FR - Francia 23
IN - India 16
CZ - Repubblica Ceca 14
JP - Giappone 9
CA - Canada 6
BE - Belgio 5
EU - Europa 5
HK - Hong Kong 5
PL - Polonia 4
IL - Israele 3
AU - Australia 2
ID - Indonesia 2
KR - Corea 2
MX - Messico 2
BR - Brasile 1
DK - Danimarca 1
HR - Croazia 1
IR - Iran 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MN - Mongolia 1
NL - Olanda 1
PA - Panama 1
RO - Romania 1
Totale 7.189
Città #
Ann Arbor 1.105
Princeton 518
Chandler 509
Wilmington 468
Jacksonville 429
Houston 247
Woodbridge 201
Ashburn 188
Dublin 187
Izmir 165
Singapore 163
Dong Ket 136
Nanjing 112
Andover 104
Beijing 90
Boardman 85
Salerno 69
Pellezzano 64
Düsseldorf 55
Norwalk 53
Dearborn 44
Shenyang 43
Nanchang 39
Fairfield 34
Mestre 34
Naples 31
Hebei 29
Redwood City 26
Jiaxing 25
Changsha 19
Tianjin 18
Pune 16
Rome 15
San Diego 15
Dallas 14
Washington 14
Milan 13
Guangzhou 10
West Jordan 10
Cambridge 7
Santa Maria A Vico 7
Dormagen 6
Fuzhou 6
Hefei 6
Jinan 6
Napoli 6
San Francisco 6
Wuhan 6
Brussels 5
Fukushima 5
Hangzhou 5
Kunming 5
Los Angeles 5
Sant'arpino 5
Brno 4
Casoria 4
Frankfurt am Main 4
Lappeenranta 4
Seattle 4
Canzo 3
Caserta 3
New York 3
Orange 3
Ottawa 3
Santa Clara 3
Zhengzhou 3
Assago 2
Casavatore 2
Clifton 2
College Park 2
Eboli 2
Esslingen am Neckar 2
Falkenstein 2
Fisciano 2
Fucecchio 2
Hanover 2
Helsinki 2
Littleton 2
Newcastle upon Tyne 2
Nocera Inferiore 2
Phoenix 2
Plymouth 2
Seo-gu 2
Solna 2
Springfield 2
Surabaya 2
Taizhou 2
Umeda 2
Vitry-le-François 2
Wenzhou 2
Airdrie 1
Albany 1
Amsterdam 1
Angri 1
Assèmini 1
Atlanta 1
Bologna 1
Brugherio 1
Böblingen 1
Calgary 1
Totale 5.582
Nome #
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 123
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 119
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 107
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 106
Increased bilirubin levels in de novo Parkinson's disease 100
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 96
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 93
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. 92
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 90
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study 87
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 83
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 83
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 82
Gender and non motor fluctuations in Parkinson's disease: A prospective study 82
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 82
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 82
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 81
Quitting smoking: An early non-motor feature of Parkinson's disease? 80
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 79
Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait 78
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 78
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 77
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 77
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 76
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 76
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 73
Music Therapy for Motor and Nonmotor Symptoms of Parkinson's Disease: A Prospective, Randomized, Controlled, Single-Blinded Study 73
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 73
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 71
Comment on Szewczyk-Krolikowski et al.: The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort 70
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 70
Uric acid relates to dopamine transporter availability in Parkinson's disease. 69
Gait patterns in Parkinsonian patients with or without mild cognitive impairment. 69
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 69
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 69
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 69
Abnormal eating behaviors in progressive supranuclear palsy. 68
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 68
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness aspresenting symptoms of PARK-2 67
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 67
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 66
Multiple system atrophy is associated with changes in peripheral insulin-like growth factor system 64
Gender differences in non-motor symptoms in early Parkinson's disease: A 2-years follow-up study on previously untreated patients. 64
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 64
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 63
Vestibular impairment and adaptive postural imbalance in parkinsonian patients with lateral trunk flexion 62
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 62
Bisphenol A glucuronidation in patients with Parkinson's disease 62
Parkinson’s disease and the spectrum of Lewy body disease 62
null 61
Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease 59
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 59
Cognitive contributions to gait and falls: Evidence and implications 59
Caratteristiche Cliniche 59
The "eye of the tiger" sign in pure akinesia with gait freezing. 58
Neuropsychological correlates of theory of mind in patients withearly Parkinson's disease. 58
Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease? 58
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 58
Ropinirole as a treatment of restless legs syndrome in patients on chronichemodialysis: an open randomized crossover trial versus levodopa sustainedrelease 57
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 57
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 57
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 56
Resting brain networks in patients with Parkinson's disease and freezing of gait 56
Hemi-restless legs syndrome induced by clebopride 56
Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism 55
Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson’s disease 55
Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients. 53
Freezing of gait and executive functions in patients with Parkinson's disease. 52
Longitudinal Changes Of Dopamine Transporter In Early-Onset Parkin Disease Measured With 123Fr-Cit Spect 52
Mild cognitive impairment in drug-naive patients with PD is associated withcerebral hypometabolism 51
Freezing of gait and executive functions in patients with Parkinson’s disease 51
Exercise dependence induced by pramipexole in Parkinson's Disease-a case report. 50
Comparative neuropsychological profile of pathological gambling, hypersexuality and compulsive eating in Parkinson’s disease. 50
Ropinirole as treatment of restless leg sindrome in patients on chrnic hemodyalisis: an open randomized, crossover trial versus levodopa sustained release 50
Frontal dysfunction contributes to the genesis of hallucinations in non-demented Parkinsonian patients 49
Future thinking in Parkinson's disease: An executive function? 49
Resting-state brain networks in patients with Parkinson's disease and impulse control disorders 49
Neuropsychological Correlates Of Major Depressive Episode In Parkinson’s Diesease 49
Classifying Different Stages of Parkinson’s Disease Through Random Forests 49
Parkinsonism and essential tremor in a family with pseudo-dominant inheritance ofPARK2: an FP-CIT SPECT study 48
Apathy in Parkinson's disease: differences between caregiver's report and self-evaluation 48
Metabolomics in Parkinson's disease 48
Serum IGF-1 is associated with cognitive functions in early, drug-naive Parkinson's disease 47
Impact of anxiety, apathy and reduced functional autonomy on perceived quality of life in Parkinson's disease 46
Gait patterns and cognition in Parkinson's disease 46
Reversible Pisa syndrome in patients with Parkinson's disease on rasagiline therapy. 45
An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population 45
Development of software tool for quantitative gait assessment in Parkinsonian patients with and without Mild Cognitive Impairment 44
Demenza nella malattia di Parkinson 44
Neuropsychiatric disturbances in parkinsonian patients with and without freezing of gait 43
Imaging of dopaminergic dysfunction with 123FP-CIT SPECT in eary-onset parkin disease 43
The use of smell identification test in Parkinson's disease in Italy: Preliminary data 43
“Response to Apomorphine in early Parkinson’s disease”. 42
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 42
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 42
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 41
A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study 40
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 39
Depression, Apathy, Anhedonia, and Fatigue in Parkinson’s Disease 36
Future thinking in Parkinson's disease: The contribution of executive functions 35
Totale 6.362
Categoria #
all - tutte 28.545
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.545


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020629 0 0 105 13 52 24 91 18 73 74 163 16
2020/2021722 3 55 62 0 107 60 83 6 68 3 95 180
2021/2022829 9 2 12 14 6 1 7 33 112 117 120 396
2022/20231.274 154 67 37 114 203 295 11 111 185 12 61 24
2023/2024772 44 105 40 42 29 90 25 63 35 57 108 134
2024/2025120 78 20 22 0 0 0 0 0 0 0 0 0
Totale 7.561